Related Experiment Video
Updated: Mar 8, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
White Matter Abnormalities in Two Different Subtypes of Amnestic Mild Cognitive Impairment
Jianghong Liu1, Peipeng Liang2,3, Linlin Yin4
1Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China.
Abstract:
White matter (WM) degeneration has been found during the course of cognitive decline in both Alzheimer's disease (AD) and amnestic mild cognitive impairment (aMCI), however, it is unclear whether there are different WM microstructural abnormalities between two subtypes of aMCI, including single domain aMCI (aMCI-s) and multiple domain aMCI (aMCI-m). Thirty-two patients of aMCI single-domain (aMCI-s), twenty-three patients of aMCI multiple-domain (aMCI-m) and twenty-three healthy normal controls (NC) participated in this study. Neuropsychological measures and diffusion tensor imaging (DTI) data were acquired from each subject and tract-based spatial statistics (TBSS) was implemented. It was found that both aMCI groups showed significantly reduced fractional anisotropy (FA) in the right superior longitudinal fasciculus (SLF) than NC. It was also identified that, as compared to aMCI-m, aMCI-s showed significantly decreased FA in the left SLF, left uncinate fasciculus (UF) and left inferior longitudinal fasciculus (ILF), while significantly increased FA in the left anterior thalamic radiation (ATR). The correlation analysis showed that FA values in the regions with group difference were significantly correlated with cognitive functions as measured by Boston naming test and trail making test. These results suggested that the variations of aMCI may be differentiated by FA indexes and DTI may help to understand why specific signs and symptoms occur in patients.
Insights
White matter degeneration is common in cognitive decline. Diffusion tensor imaging reveals distinct white matter abnormalities in single-domain versus multiple-domain amnestic mild cognitive impairment, differentiating these subtypes.
Area of Science:
- Neuroimaging
- Neurology
- Cognitive Science
Background:
- White matter (WM) degeneration is observed in Alzheimer's disease (AD) and amnestic mild cognitive impairment (aMCI).
- Distinguishing microstructural abnormalities between single-domain aMCI (aMCI-s) and multiple-domain aMCI (aMCI-m) remains unclear.
Purpose of the Study:
- To investigate differences in white matter (WM) microstructural integrity between aMCI subtypes.
- To explore the relationship between WM abnormalities and cognitive function.
Main Methods:
- Diffusion tensor imaging (DTI) and tract-based spatial statistics (TBSS) were used.
- Neuropsychological measures were administered to 32 aMCI-s, 23 aMCI-m, and 23 healthy normal controls (NC).
Main Results:
- Both aMCI groups exhibited reduced fractional anisotropy (FA) in the right superior longitudinal fasciculus (SLF) compared to NC.
- aMCI-s showed decreased FA in the left SLF, left uncinate fasciculus (UF), and left inferior longitudinal fasciculus (ILF) compared to aMCI-m.
- aMCI-s also demonstrated increased FA in the left anterior thalamic radiation (ATR) relative to aMCI-m.
- FA values in differing regions correlated significantly with cognitive test performance (Boston naming test, trail making test).
Conclusions:
- Fractional anisotropy (FA) indexes derived from DTI can differentiate between aMCI subtypes.
- DTI may provide insights into the specific signs and symptoms observed in aMCI patients.
Related Concept Videos
Amnesia
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

